Jubilant DraxImage is dedicated to providing radiopharmaceuticals for the diagnosis and treatment of a variety of diseases. We invite you to learn more about these areas and how our products are used by healthcare professionals to care for their patients.
Rubidium-82 – An Alternative Radiopharmaceutical for Myocardial Imaging (Rb-ARMI)
In 2014 Canadian Rubidium-82 PET imaging sites transitioned from the Rb-ARMI clinical trial to the REST-PET (Rubidium Elution System Testing) device trial.
There were five clinical sites in Canada registered under the REST-PET trial: the University of Ottawa Heart Institute (Ottawa, ON) is the study sponsor and coordinating centre / St. Joseph’s Healthcare (Hamilton, ON) / KMH Cardiology (Toronto, ON) / University of Alberta Hospital (Edmonton, AB) and Institut Universitaire de Cardiologie et Pneumologie de Québec (Québec, QC).
For more information on the ARMI Trial, please visit: www.clinicaltrials.gov/ct2/show/NCT01128023